Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Revenue

Par Drugs and Chemicals had revenue of 312.81M INR in the quarter ending June 30, 2026, with 20.10% growth. This brings the company's revenue in the last twelve months to 1.09B, up 4.29% year-over-year. In the fiscal year ending March 31, 2026, Par Drugs and Chemicals had annual revenue of 1.04B with 2.66% growth.

• Revenue (ttm): 1.09B
• Revenue Growth: +4.29%
• P/S Ratio: 1.15
• Revenue / Employee: 9.00M
• Employees: 121
• Market Cap: 1.25B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.04B	26.82M	2.66%
Mar 31, 2025	1.01B	53.33M	5.58%
Mar 31, 2024	956.40M	-1.08M	-0.11%
Mar 31, 2023	957.49M	206.74M	27.54%
Mar 31, 2022	750.74M	143.23M	23.58%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error